The MarketWatch News Department was not involved in the creation of this content. TriNetX(R) will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase(R) ...
TriNetX, the state-of-the-art end-user query tool that allows users to search de-identified clinical patient data for feasibility, recruitment, and project enrollment, is available to University at ...
TriNetX uses a network of healthcare organizations’ research repositories, cancer and genomics registries, and some electronic health records systems. This UB CTSI Watch and Learn educational module ...
Regeneron (REGN) has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data Collaboration will ...
TARRYTOWN, N.Y. and CAMBRIDGE, Mass. - Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced today a collaboration with TriNetX to access de-identified electronic health record data from ...
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to ...
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results